Report Overview
Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.
The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.
Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
This report provides a deep insight into the global Cancer Drug Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Drug Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Drug Therapy market in any manner.
Global Cancer Drug Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Market Segmentation (by Type)
Targeted Therapy
Chemotherapy
Immunotherapy
Market Segmentation (by Application)
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Cancer Drug Therapy Market
? Overview of the regional outlook of the Cancer Drug Therapy Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Drug Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cancer Drug Therapy
1.2 Key Market Segments
1.2.1 Cancer Drug Therapy Segment by Type
1.2.2 Cancer Drug Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cancer Drug Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Cancer Drug Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cancer Drug Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cancer Drug Therapy Market Competitive Landscape
3.1 Global Cancer Drug Therapy Sales by Manufacturers (2019-2024)
3.2 Global Cancer Drug Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Drug Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Drug Therapy Sales Sites, Area Served, Product Type
3.6 Cancer Drug Therapy Market Competitive Situation and Trends
3.6.1 Cancer Drug Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Drug Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cancer Drug Therapy Industry Chain Analysis
4.1 Cancer Drug Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cancer Drug Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cancer Drug Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Drug Therapy Sales Market Share by Type (2019-2024)
6.3 Global Cancer Drug Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Drug Therapy Price by Type (2019-2024)
7 Cancer Drug Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Drug Therapy Market Sales by Application (2019-2024)
7.3 Global Cancer Drug Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Drug Therapy Sales Growth Rate by Application (2019-2024)
8 Cancer Drug Therapy Market Segmentation by Region
8.1 Global Cancer Drug Therapy Sales by Region
8.1.1 Global Cancer Drug Therapy Sales by Region
8.1.2 Global Cancer Drug Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Drug Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Drug Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Drug Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Drug Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Drug Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen / Allergan
9.1.1 Amgen / Allergan Cancer Drug Therapy Basic Information
9.1.2 Amgen / Allergan Cancer Drug Therapy Product Overview
9.1.3 Amgen / Allergan Cancer Drug Therapy Product Market Performance
9.1.4 Amgen / Allergan Business Overview
9.1.5 Amgen / Allergan Cancer Drug Therapy SWOT Analysis
9.1.6 Amgen / Allergan Recent Developments
9.2 Argos Therapeutics
9.2.1 Argos Therapeutics Cancer Drug Therapy Basic Information
9.2.2 Argos Therapeutics Cancer Drug Therapy Product Overview
9.2.3 Argos Therapeutics Cancer Drug Therapy Product Market Performance
9.2.4 Argos Therapeutics Business Overview
9.2.5 Argos Therapeutics Cancer Drug Therapy SWOT Analysis
9.2.6 Argos Therapeutics Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Cancer Drug Therapy Basic Information
9.3.2 AstraZeneca Cancer Drug Therapy Product Overview
9.3.3 AstraZeneca Cancer Drug Therapy Product Market Performance
9.3.4 AstraZeneca Cancer Drug Therapy SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Aveo Pharmaceuticals
9.4.1 Aveo Pharmaceuticals Cancer Drug Therapy Basic Information
9.4.2 Aveo Pharmaceuticals Cancer Drug Therapy Product Overview
9.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Product Market Performance
9.4.4 Aveo Pharmaceuticals Business Overview
9.4.5 Aveo Pharmaceuticals Recent Developments
9.5 Bayer
9.5.1 Bayer Cancer Drug Therapy Basic Information
9.5.2 Bayer Cancer Drug Therapy Product Overview
9.5.3 Bayer Cancer Drug Therapy Product Market Performance
9.5.4 Bayer Business Overview
9.5.5 Bayer Recent Developments
9.6 Exelixis
9.6.1 Exelixis Cancer Drug Therapy Basic Information
9.6.2 Exelixis Cancer Drug Therapy Product Overview
9.6.3 Exelixis Cancer Drug Therapy Product Market Performance
9.6.4 Exelixis Business Overview
9.6.5 Exelixis Recent Developments
9.7 Incyte
9.7.1 Incyte Cancer Drug Therapy Basic Information
9.7.2 Incyte Cancer Drug Therapy Product Overview
9.7.3 Incyte Cancer Drug Therapy Product Market Performance
9.7.4 Incyte Business Overview
9.7.5 Incyte Recent Developments
9.8 Merck
9.8.1 Merck Cancer Drug Therapy Basic Information
9.8.2 Merck Cancer Drug Therapy Product Overview
9.8.3 Merck Cancer Drug Therapy Product Market Performance
9.8.4 Merck Business Overview
9.8.5 Merck Recent Developments
9.9 Roche
9.9.1 Roche Cancer Drug Therapy Basic Information
9.9.2 Roche Cancer Drug Therapy Product Overview
9.9.3 Roche Cancer Drug Therapy Product Market Performance
9.9.4 Roche Business Overview
9.9.5 Roche Recent Developments
9.10 Bristol-Myers Squibb
9.10.1 Bristol-Myers Squibb Cancer Drug Therapy Basic Information
9.10.2 Bristol-Myers Squibb Cancer Drug Therapy Product Overview
9.10.3 Bristol-Myers Squibb Cancer Drug Therapy Product Market Performance
9.10.4 Bristol-Myers Squibb Business Overview
9.10.5 Bristol-Myers Squibb Recent Developments
9.11 Eisai
9.11.1 Eisai Cancer Drug Therapy Basic Information
9.11.2 Eisai Cancer Drug Therapy Product Overview
9.11.3 Eisai Cancer Drug Therapy Product Market Performance
9.11.4 Eisai Business Overview
9.11.5 Eisai Recent Developments
9.12 Exelixis
9.12.1 Exelixis Cancer Drug Therapy Basic Information
9.12.2 Exelixis Cancer Drug Therapy Product Overview
9.12.3 Exelixis Cancer Drug Therapy Product Market Performance
9.12.4 Exelixis Business Overview
9.12.5 Exelixis Recent Developments
9.13 Genentech (Roche)
9.13.1 Genentech (Roche) Cancer Drug Therapy Basic Information
9.13.2 Genentech (Roche) Cancer Drug Therapy Product Overview
9.13.3 Genentech (Roche) Cancer Drug Therapy Product Market Performance
9.13.4 Genentech (Roche) Business Overview
9.13.5 Genentech (Roche) Recent Developments
9.14 Novartis
9.14.1 Novartis Cancer Drug Therapy Basic Information
9.14.2 Novartis Cancer Drug Therapy Product Overview
9.14.3 Novartis Cancer Drug Therapy Product Market Performance
9.14.4 Novartis Business Overview
9.14.5 Novartis Recent Developments
9.15 Pfizer
9.15.1 Pfizer Cancer Drug Therapy Basic Information
9.15.2 Pfizer Cancer Drug Therapy Product Overview
9.15.3 Pfizer Cancer Drug Therapy Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Prometheus Labs
9.16.1 Prometheus Labs Cancer Drug Therapy Basic Information
9.16.2 Prometheus Labs Cancer Drug Therapy Product Overview
9.16.3 Prometheus Labs Cancer Drug Therapy Product Market Performance
9.16.4 Prometheus Labs Business Overview
9.16.5 Prometheus Labs Recent Developments
10 Cancer Drug Therapy Market Forecast by Region
10.1 Global Cancer Drug Therapy Market Size Forecast
10.2 Global Cancer Drug Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Drug Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Drug Therapy Market Size Forecast by Region
10.2.4 South America Cancer Drug Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cancer Drug Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cancer Drug Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cancer Drug Therapy by Type (2025-2030)
11.1.2 Global Cancer Drug Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cancer Drug Therapy by Type (2025-2030)
11.2 Global Cancer Drug Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Cancer Drug Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Cancer Drug Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Drug Therapy Market Size Comparison by Region (M USD)
Table 5. Global Cancer Drug Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Cancer Drug Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cancer Drug Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cancer Drug Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2022)
Table 10. Global Market Cancer Drug Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cancer Drug Therapy Sales Sites and Area Served
Table 12. Manufacturers Cancer Drug Therapy Product Type
Table 13. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cancer Drug Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Drug Therapy Market Challenges
Table 22. Global Cancer Drug Therapy Sales by Type (Kilotons)
Table 23. Global Cancer Drug Therapy Market Size by Type (M USD)
Table 24. Global Cancer Drug Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Cancer Drug Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Cancer Drug Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Cancer Drug Therapy Market Size Share by Type (2019-2024)
Table 28. Global Cancer Drug Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Cancer Drug Therapy Sales (Kilotons) by Application
Table 30. Global Cancer Drug Therapy Market Size by Application
Table 31. Global Cancer Drug Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Cancer Drug Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Cancer Drug Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Cancer Drug Therapy Market Share by Application (2019-2024)
Table 35. Global Cancer Drug Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Cancer Drug Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Cancer Drug Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Cancer Drug Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Cancer Drug Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Cancer Drug Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Cancer Drug Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Cancer Drug Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Amgen / Allergan Cancer Drug Therapy Basic Information
Table 44. Amgen / Allergan Cancer Drug Therapy Product Overview
Table 45. Amgen / Allergan Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Amgen / Allergan Business Overview
Table 47. Amgen / Allergan Cancer Drug Therapy SWOT Analysis
Table 48. Amgen / Allergan Recent Developments
Table 49. Argos Therapeutics Cancer Drug Therapy Basic Information
Table 50. Argos Therapeutics Cancer Drug Therapy Product Overview
Table 51. Argos Therapeutics Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Argos Therapeutics Business Overview
Table 53. Argos Therapeutics Cancer Drug Therapy SWOT Analysis
Table 54. Argos Therapeutics Recent Developments
Table 55. AstraZeneca Cancer Drug Therapy Basic Information
Table 56. AstraZeneca Cancer Drug Therapy Product Overview
Table 57. AstraZeneca Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AstraZeneca Cancer Drug Therapy SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Aveo Pharmaceuticals Cancer Drug Therapy Basic Information
Table 62. Aveo Pharmaceuticals Cancer Drug Therapy Product Overview
Table 63. Aveo Pharmaceuticals Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Aveo Pharmaceuticals Business Overview
Table 65. Aveo Pharmaceuticals Recent Developments
Table 66. Bayer Cancer Drug Therapy Basic Information
Table 67. Bayer Cancer Drug Therapy Product Overview
Table 68. Bayer Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bayer Business Overview
Table 70. Bayer Recent Developments
Table 71. Exelixis Cancer Drug Therapy Basic Information
Table 72. Exelixis Cancer Drug Therapy Product Overview
Table 73. Exelixis Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Exelixis Business Overview
Table 75. Exelixis Recent Developments
Table 76. Incyte Cancer Drug Therapy Basic Information
Table 77. Incyte Cancer Drug Therapy Product Overview
Table 78. Incyte Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Incyte Business Overview
Table 80. Incyte Recent Developments
Table 81. Merck Cancer Drug Therapy Basic Information
Table 82. Merck Cancer Drug Therapy Product Overview
Table 83. Merck Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Merck Business Overview
Table 85. Merck Recent Developments
Table 86. Roche Cancer Drug Therapy Basic Information
Table 87. Roche Cancer Drug Therapy Product Overview
Table 88. Roche Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Roche Business Overview
Table 90. Roche Recent Developments
Table 91. Bristol-Myers Squibb Cancer Drug Therapy Basic Information
Table 92. Bristol-Myers Squibb Cancer Drug Therapy Product Overview
Table 93. Bristol-Myers Squibb Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Recent Developments
Table 96. Eisai Cancer Drug Therapy Basic Information
Table 97. Eisai Cancer Drug Therapy Product Overview
Table 98. Eisai Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Eisai Business Overview
Table 100. Eisai Recent Developments
Table 101. Exelixis Cancer Drug Therapy Basic Information
Table 102. Exelixis Cancer Drug Therapy Product Overview
Table 103. Exelixis Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Exelixis Business Overview
Table 105. Exelixis Recent Developments
Table 106. Genentech (Roche) Cancer Drug Therapy Basic Information
Table 107. Genentech (Roche) Cancer Drug Therapy Product Overview
Table 108. Genentech (Roche) Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Genentech (Roche) Business Overview
Table 110. Genentech (Roche) Recent Developments
Table 111. Novartis Cancer Drug Therapy Basic Information
Table 112. Novartis Cancer Drug Therapy Product Overview
Table 113. Novartis Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Novartis Business Overview
Table 115. Novartis Recent Developments
Table 116. Pfizer Cancer Drug Therapy Basic Information
Table 117. Pfizer Cancer Drug Therapy Product Overview
Table 118. Pfizer Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Pfizer Business Overview
Table 120. Pfizer Recent Developments
Table 121. Prometheus Labs Cancer Drug Therapy Basic Information
Table 122. Prometheus Labs Cancer Drug Therapy Product Overview
Table 123. Prometheus Labs Cancer Drug Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Prometheus Labs Business Overview
Table 125. Prometheus Labs Recent Developments
Table 126. Global Cancer Drug Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Cancer Drug Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Cancer Drug Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Cancer Drug Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Cancer Drug Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Cancer Drug Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Cancer Drug Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Cancer Drug Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Cancer Drug Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Cancer Drug Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Cancer Drug Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Cancer Drug Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Cancer Drug Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Cancer Drug Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Cancer Drug Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Cancer Drug Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Cancer Drug Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Cancer Drug Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Drug Therapy Market Size (M USD), 2019-2030
Figure 5. Global Cancer Drug Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Cancer Drug Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Drug Therapy Market Size by Country (M USD)
Figure 11. Cancer Drug Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Cancer Drug Therapy Revenue Share by Manufacturers in 2023
Figure 13. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cancer Drug Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cancer Drug Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cancer Drug Therapy Market Share by Type
Figure 18. Sales Market Share of Cancer Drug Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Cancer Drug Therapy by Type in 2023
Figure 20. Market Size Share of Cancer Drug Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Cancer Drug Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Drug Therapy Market Share by Application
Figure 24. Global Cancer Drug Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Cancer Drug Therapy Sales Market Share by Application in 2023
Figure 26. Global Cancer Drug Therapy Market Share by Application (2019-2024)
Figure 27. Global Cancer Drug Therapy Market Share by Application in 2023
Figure 28. Global Cancer Drug Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cancer Drug Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Cancer Drug Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Cancer Drug Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Cancer Drug Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Cancer Drug Therapy Sales Market Share by Country in 2023
Figure 37. Germany Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Cancer Drug Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Cancer Drug Therapy Sales Market Share by Region in 2023
Figure 44. China Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Cancer Drug Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Cancer Drug Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Cancer Drug Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Cancer Drug Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Cancer Drug Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Cancer Drug Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Cancer Drug Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cancer Drug Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cancer Drug Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Cancer Drug Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Cancer Drug Therapy Market Share Forecast by Application (2025-2030)
